We never want patients to feel they must choose between effective treatment and quality of life. Proactive monitoring can help you identify problems before they become serious: The rapid weight loss that often accompanies GLP-1 therapy requires nutritional vigilance
Our clinical staff is trained to monitor patients closely during and after the procedure for any signs of an adverse reaction
The findings can provide some reassurance for pregnant women with unintentional first trimester exposure to GLP-1 RAs, however, further research is warranted to better understand the safety of these medications during pregnancy
Clinical experience suggests that patients who maintain 150+ minutes of weekly physical activity and prioritize protein intake experience slower weight regain if they stop GLP-1 therapy
GSH is the most important intracellular antioxidant thiol, and the liver is its main source [15]
Rather than relying on aggressive dosing, MEDVi emphasizes consistency and clinical oversight to align weight reduction with broader health metrics